Ameriprise Financial Inc Cyma Bay Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.63 - $24.47 $324,729 - $629,148	25,711 New	25,711 $607,000
Q4 2022 Feb 14, 2023	SELL	$3.22 - $6.27 $22,379 - $43,576	-6,950 Reduced 37.55%	11,561 $72,000
Q3 2022 Nov 14, 2022	SELL	$2.77 - $4.25 $10,387 - $15,937	-3,750 Reduced 16.85%	18,511 $65,000
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $2,408 - $4,746	-1,400 Reduced 5.92%	22,261 $66,000
Q1 2022 May 16, 2022	BUY	$2.77 - $3.64 $415 - $546	150 Added 0.64%	23,661 $74,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $4.6 $29,502 - $42,016	-9,134 Reduced 27.98%	23,511 $79,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $5,916 - $7,536	-1,705 Reduced 4.96%	32,645 $120,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $4.92 $5,023 - $6,273	-1,275 Reduced 3.58%	34,350 $149,000
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $34,584 - $53,552	-8,176 Reduced 18.67%	35,625 $161,000
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $69,361 - $109,308	12,105 Added 38.19%	43,801 $243,000
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $48,721 - $106,247	14,675 Added 86.22%	31,696 $229,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $23,999 - $72,339	17,021 New	17,021 $60,000
Q4 2019 Feb 14, 2020	SELL	$1.33 - $5.93 $22,633 - $100,916	-17,018 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $768 - $1,081	150 Added 0.89%	17,018 $87,000
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $5,511 - $12,444	-911 Reduced 5.12%	16,868 $121,000
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $4,569 - $7,515	560 Added 3.25%	17,779 $236,000
Q4 2018 Feb 14, 2019	BUY	$6.54 - $11.74 $11,379 - $20,427	1,740 Added 11.24%	17,219 $136,000
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $11,532 - $15,391	1,060 Added 7.35%	15,479 $171,000
Q2 2018 Aug 14, 2018	SELL	$10.66 - $14.38 $790,609 - $1.07 Million	-74,166 Reduced 83.72%	14,419 $194,000
Q1 2018 May 15, 2018	SELL	$9.0 - $15.16 $710,631 - $1.2 Million	-78,959 Reduced 47.13%	88,585 $1.15 Million
Q4 2017 Feb 12, 2018	SELL	$7.67 - $9.31 $176,072 - $213,720	-22,956 Reduced 12.05%	167,544 $1.54 Million
Q3 2017 Nov 07, 2017	BUY	$5.95 - $8.26 $1.13 Million - $1.57 Million	190,500	190,500 $1.54 Million

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account